Диссертация (1173317), страница 21
Текст из файла (страница 21)
13–17.doi: 10.1097/ACI.0b013e32834eccdb.39. Adams, J. S. Unexpected actions of vitamin D: new perspectives on theregulation of innate and adaptive immunity / J. S. Adams, M. Hewison. // NatureClinical Practice Endocrinology & Metabolism. - 2008. – Vol. 4, № 2. – P. 80–90.doi:10.1038/ncpendmet071640. Akdemir, N. The correlation of serum asymmetric dimethylarginine and antiMüllerian hormone in primary dysmenorrhea / N. Akdemir, F. B. Cinemre, M.
S.Bostancı [et al.] // Kaohsiung J. Med. Sci. – 2016. – Vol. 32, № 8. – P. 414-419. doi:10.1016/j.kjms.2016.07.00141. Akerlund, M. Vasopressin and oxytocin in normal reproduction and in thepathophysiology of preterm labour and primary dysmenorrhoea. Developmentofreceptor antagonists for therapeutic use in these conditions / M. Akerlund // Rocz.Akad. MedBialymst. – 2004. - № 49.
– P. 18–21.42. Altunyurt, S. Primary dysmenorrhea and uterine blood flow: a color Dopplerstudy / S. Altunyurt, M. Gol, O. Sezer [et al.] // J. Reprod. Med. – 2005. - № 50. – P.251–255.43. American College of Obstetricians and Gynecologists. ACOG practice bulletinno. 110: noncontraceptive uses of hormonal contraceptives// Obstet. Gynecol. – 2010.Vol. 115, № 1. – P. 206–218.44. Andersch, B. An epidemiological study of young women with dysmenorrhea / B.Andersch, I. Milsom // Am. J. Obstet.
Gynecol. – 1982. - № 144. – P. 655–660.45. Araujo, P. Sleep pattern in women with menstrual pain / P. Araujo, H. Hachul, R.Santos-Silva, L. R. Bittencourt [et al.] // Sleep Med. – 2011. - № 12. – P. 1028–1030.46. Ashraf, M. The effect of vitamin D on primary dysmenorrhea with vitamin Ddeficiency: a randomized double-blind controlled clinical trial / M. Ashraf, T. Ebrahimi,N. Shirzad [et al.] // Gynecological Endocrinology. – 2016.
– Vol. 32, № 6. – P. 502505. DOI: 10.3109/09513590.2015.113661712747. Babic, A. Menstrual pain and epithelial ovarian cancer risk / A. Barbic, D.Cramer, L. Titus [et al.] // Cancer Causes Control. – 2014. – Vol. 25, N 12. – P. 1725–1731. doi:10.1007/s10552-014-0463-648. Batool, T. The Efficacy of Zinc Administration in the Treatment of PrimaryDysmenorrhea / T. Batool, M. Ghasemi, Z. Sadat [et al.] // Oman Med.
J. – 2016.- Vol.31, N 2. – P. 107–111. doi:10.5001/omj.2016.2149. Beighton, P. Ehlers-Danlos Syndromes: Revised Nosology, Villefranche. /P.Beighton, A. De Paepe , B. Steinmann // Amer. J. Med. Genet. - 1998. - Vol.77. - P. 3137.50. Benedetto, C. Eicosanoids in primary dysmenorrhea, endometriosis andmenstrual migraine / C. Benedetto // Gynecol. Endocrinol.
– 1989. – Vol. 3, N 1. – P.71-94.51. Berbic, M. Inflammation and endometrial bleeding / M. Berbic, I. S. Fraser //Climacteric. – 2014. – N 17. – P. 47-53.52. Berkley, K. J. Don’t dismiss dysmenorrhea!/ K. J. Berkley, S. L. McAllister //Pain. – 2011. - N 152. – P. 1940–1941.53.54. Bieglmayer, C. Concentrations of various arachidonic acid metabolites inmenstrual fluid are assosciated with menstrual pain and are influenced by hormonalcontraceptives / C. Bieglmayer, G. Hofer, C. Kainz [et al.] // Gynaecol. Endocrinol.
–1995. – N 9. – P. 307–312.55. Brinckerhoff, C. E. Matrix metalloproteinases: a tail of a frog that became aprince / C. E. Brinckerhoff, L. M. Matrisian // Nat. Rev. Mol. Cell Biol. – 2002. – Vol.3, N 3. – P. 207–14. doi:10.1038/nrm76356. Chan, W. Y. Prostaglandins in primary dysmenorrhea. Comparison ofprophylactic and nonprophylactic treatment with ibuprofen and use of oralcontraceptives / W. Y. Chan, M.
Y. Dawood, F. Fuchs// Am. J. Med. - 1981. - Vol. 70. P. 535–541.12857. Chen, H.Y. Matrix metalloproteinase-9 polymorphism and risk of pelvic organprolapse in Taiwanese women / H. Y. Chen, W. Y. Lin, Y. H. Chen [et al.] // Eur. J.Obstet. Gynecol.Reprod. Biol. — 2010. — Vol. 149, N 2. — P.
222–224.58. Clark, J. D. A novel arachidonic acid-selective cytosolic PLA sub 2 contains a Ca(2 sup +) -dependent translocation domain with homology to PKC and GAP / J. D.Clark, L. L. Lin, R. W. Kriz [et al.] // Cell. – 1991. - N 65. – P. 1043–1051.59. Colombo, F. Comparative evaluation of the efficacy of naproxen sodium andibuprofen in the treatment of primary dysmenorrhea // / F. Colombo // Ann. Ostet.Ginecol. Med. Perinat. - 1990.
- Vol. 111, N 3. - P. 205–208.60. Dawood, M. Y. Nonsteroidal anti-inflammatory drugs and changing attitudestoward dysmenorrhea / M. Y. Dawood // Am. J. Med.- 1988.- Vol. 84.- P. 23-29.61. Dawood, M. Y. Primary dysmenorrhea: advances in pathogenesis andmanagement / M. Y. Dawood // Obstetric Gynecology. - 2006. - Vol. 108, N 2. - P.428–441.62.
DeLuca, H.F. Vitamin D: its role and uses in immunology / H. F. DeLuca, M. T.Cantorna // FASEB J. – 2001. – N 15. – P. 2579–2585.63. Demirtürk, F. Comparison of reflexology and connective tissue manipulation inparticipants with primary dysmenorrhea / F. Demirtürk, Z. Y. Erkek //AlternJ.Complement Med. – 2016. – Vol 22, N 1. – P. 38-44. Doi:10.1089/acm.2015.0050.64. Differentialregulationofmatrixmetalloproteinase2andmatrixmetalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoidarthritis / M. Xue [et al.] // Arthritis Rheum. – 2007. – Vol.
56, N 9. – P. 2864-2874.doi.org/10.5493/wjem.v3.i3.4365.Durain, D. Primary dysmenorrhea: assessment and management update / D.Durain // Journal of Midwifery & Women's Health. - 2004. - Vol. 49, № 6. - P. 520-528.66. Dysmenorrhoea. Latthe P.M. //BMJ Clin Evid. 2011 Feb 21; 2011. pii: 0813.67. ESHRE, 2013. Guideline for the Diagnosis and Treatment of Endometriosis /G.A. Dunselman [et al.] // Hum Reprod. – 2014.
– Vol. 29, N 3. – P. 400-412. doi:10.1093/humrep/det457.12968. Farmer, M.A. A dynamic network perspective of chronic pain / M. A. Farmer, M.N. Baliki, A. V. Apkarian // Neurosci. Lett. – 2012. – N 520. – P. 197–203.69. Ferrell, С. In adolescent females with primary dysmenorrhea, are oralcontraceptive agents as effective as nonsteroidal anti-inflammatory drugs (NSAIDs) forreducing abdominal pain? / C.
Ferrell, P. Wright // Evidence-Based Practice. - 2008. Vol. 11, № 2. - P. 4-5.70. French, L. Dysmenorrhea in adolescents: diagnosis and treatment / L. French //Paediatric Drugs. - 2008. - Vol. 10, N 1. - P. 1–7.71. Fujiwara, H. Efficacy of montelukast, a leukotriene receptor antagonist, for thetreatment of dysmenorrheal: a prospective, double-blind, randomized, placebocontrolled study / H. Fujiwara, R. Konno, S.
Netsu [et al.] // European Journal ofObstetrics & Gynecology and Reproductive Biology. – 2010. - Vol. 148, №2. - P. 195198.72. Gargett, С. Potential role of endometrial stem/progenitor cells in the pathogenesisof early-onset endometriosis / C. Gargett, K. Schwab, J. Brosens [et al.] // Molecularhuman reproduction. – 2014. - Vol. 20, N 7. – P. 591-598.73. Garland, C.F.
Vitamin D for cancer prevention: global perspective / C.F. Garland,E.D. Gorham, S.B. Mohr, F.C. Garland // Annals of Epidemiology. – 2009. – Vol. 19, N7. P. 468-483.74. Grandi, G. Prevalence of menstrual pain in young women: what isdysmenorrhea?/ G. Grandi, S. Ferrari, A. Xholli // J Pain Res. – 2012. – N 5. – P. 169174. doi: 10.2147/JPR.S30602.75. Guerrera, M. P. Therapeutic uses of magnesium/ M.P. Guerrera, S.L. Volpe, J.J.Mao //American Family Phisician.-2009.-Vol. 80, №2.-P.157-162.76.
Halme, J. Retrograde menstruation in healthy women and in patients withendometriosis/ J. Halme, M.G. Hammond, J.F. Hulka [et al.] // Obstet Gynecol. – 1984.– N 64. – P. 151–155.77. Hanjalic-Beck, A. Nonsteroidal anti-inflammatory drugs and hormonalcontraceptives for pain relief from dysmenorrhea: a review / A. Hanjalic-Beck, H.P.Zahradnik, K. Groth // Contraception. - 2010. - Vol.
81, № 3. - P. 185-196.130doi: 10.1016/j.contraception.2009.09.014.78. Harada, T. Dysmenorrhea and endometriosis in young women. / T. Harada //Yonago Acta Med. – 2013. - N 56. – P. 81-84.79. Harel, Z. Dysmenorrhea in adolescents and young adults: an update onpharmacological treatments and management strategies [Article in French] / Z. Harel //Expert Opin Pharmacother. – 2012. – Vol. 13, N 15.
– P. 2157-2170.doi: 10.1517/14656566.2012.725045.80. Harlow, S.D. A longitudinal study of risk factors for the occurrence, duration andseverity of menstrual cramps in a cohort of college women / S.D. Harlow, M. Park // BrJ Obstet Gynaecol. – 1996. – Vol. 103, N 11. – P. 1134-114281. Iacovides, S. What we know about primary dysmenorrhea today: a critical review/ S. Iacovides, I. Avidon, F.C.
Baker // Human Reproduction. – 2015. – Vol. 21, N 6. – P.762-778 doi:10.1093/humupd/dmv03982. Iacovides, S. Women with dysmenorrhea are hypersensitive to experimental deepmuscle pain across the menstrual cycle / S. Iacovides, I. Avidon, A. Bentley, F.C. Baker// J Pain.
– 2013. – Vol. 14, N 10. - P. 1066-1076.83. Ibrahim, M.G Ultramicro-trauma in the endometrial-myometrial junctional zoneand pale cell migration in adenomyosis / M.G. Ibrahim, V. Chiantera,S. Frangini [et al.]// Fertil Steril. – 2015. – Vol. 104, N 6. – P. 1475-1483.doi: 10.1016/j.fertnstert.2015.09.00284. International Association for the Study of Pain (IASP). Classification of chronicpain / H. Merskey. Taxonomy Working Group. 2nd (revised) ed. - Seattle: IASP press,2011. – 238 p.85.
Jana, S. Regulation of Matrix Metalloproteinase-2 Activity by COX-2- PGE2pAKT Axis Promotes Angiogenesis in Endometriosis / S. Jana, K. Chatterjee, A.K. Ray[et al.] // PLoS ONE. – 2016. – Vol. 11, N 10. - e0163540.doi:10.1371/journal.pone.016354086. Jokimaa, V. Altered expression of genes involved in the production anddegradation of endometrial extracellular matrix in patients with unexplained infertility131and recurrent miscarriages / V. Jokimaa [et al.] // Molec. Human Reproduction. – 2002.– Vol.
8, N 12. – P. 1111–1116.87. Jones, G.T. Matrix metalloproteinases in biologic samples / G.T. Jones // Adv.Clin. Chem. – 2014. – Vol. 65. – P. 199-219.88. Jones, T.R. Pharmacological study of the contractile activity of leukotriene C4and D4 on isolated human airway smooth muscle / T.R. Jones, C. Davis, E.E.
Daniel //Can. J. Physiol. Pharmacol. – 1982. –N 60. – P. 638–643.89. Kaplan, Ö. Nonsteroidal anti-inflammatory drug modulates oxidative stress andcalcium ion levels in the neutrophils of patients with primary dysmenorrhea / Ö. Kaplan[et al.] // J Reprod Immunol. – 2013. – Vol. 100, N 2. – P.
87-92.doi:10.1016/j.jri.2013.10.00490. Kashefi, F. Comparison of the effect of ginger and zinc sulfate on primarydysmenorrhea: a placebo-controlled randomized trial / F. Kashefi, M. Khajehei, [et al.]// Pain Manag Nurs. – 2014. – Vol. 15, N 4. – P. 826-833.91. Kazama, M. Prevalence of Dysmenorrhea and Its Correlating Lifestyle Factors inJapanese Female Junior High School Students / M. Kazama, M. Keiko, K. Nakamura, //The Tohoku Journal of Experimental Medicine.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
